VORRICHTUNG ZUR ANALYTÜBERWACHUNG

Patent europeic · EP4460233 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4460233
Numer da la dumonda
EP23704473
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
03-01-2023
Publitgà
13-11-2024
Concedì
17-06-2026
La protecziun finescha il pli tard
02-01-2043
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61B 5/145 (2006.01)
Prioritad
US 202263296262 P 04.01.2022
Dumonda PCT
PCT/US2023/010054 03.01.2023
Publicaziun PCT
WO2023/133102 13.07.2023
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 17-06-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 17.06.2026

Partidas

Possessur

Abbott Diabetes Care Inc.

1420 Harbor Bay Parkway, Alameda, California 94502, US

Inventur

RAO, Vivek S.

Alameda, California 94502, US

SIMMONS, Matthew

Pleasanton, California 94588, US

MITCHELL, Steven T.

Pleasant Hill, California 94523, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.